Incorporating Glucagon-Like Peptide-1 Receptor Agonists in the Individualized Management of Patients with Type 2 Diabetes

Name: Incorporating Glucagon-Like Peptide-1 Receptor Agonists in the Individualized Management of Patients with Type 2 Diabetes
Start: 2020-03-20T00:00:00-05:00
End: 2020-03-20T00:00:00-05:00
Location: Enduring Material

Type 2 Diabetes

Enduring Material

Not available

1 AMA

Related events

December 08, 2025

MUSM Clinical Faculty Development Series

Learning from Adversity to Strengthen One's Surgical Career

Virtual

Mercer University School of Medicine

Arun K Gosain MD

1 AMA

Learn more

December 11, 2025

FSU-Sarasota

Update on Major Vascular Condition

Zoom

FSU College of Medicine

Russell Samson MD

2 AMA

Learn more

February 25, 2026

FSU-Orlando

Pediatric All Faculty Meeting/Update on CF Treatment and Outcomes

Orlando, Florida

ORL RMSC & ZOOM

FSU College of Medicine

Debra Andree MD and Mark Weatherly MD

2 AMA

Learn more

For almost 40 years, MECOP has been an ACCME-accredited provider of continuing medical education for physicians.

Incorporating Glucagon-Like Peptide-1 Receptor Agonists in the Individualized Management of Patients with Type 2 Diabetes

Type 2 Diabetes

Related events

MUSM Clinical Faculty Development Series

Learning from Adversity to Strengthen One's Surgical Career

FSU-Sarasota

Update on Major Vascular Condition

FSU-Orlando

Pediatric All Faculty Meeting/Update on CF Treatment and Outcomes

Upcoming Events

Quick Links

Contact Us